Cure Brain Cancer Foundation is excited to announce one of the biggest developments ever, in DIPG research history. Following a groundbreaking research project and the results of 14 years of work, Dr David Ziegler, Children’s Hospital of Sydney, has been awarded a grant by the DIPG Collaborative for a clinical trial that offers real hope to children fighting DIPG/DMG. This grant will expand the clinical trial into trial sites at 18 hospitals, worldwide.

After receiving the grant, Dr. Ziegler shared, “We think it’s the most effective drug treatment that anyone’s tested in any of the DIPG models in the lab. We are very hopeful that we are really going to make a difference.” 

This grant was awarded through the DIPG Collaborative, of which Cure Brain Cancer Foundation is a proud Foundational member. The DIPG Collaborative is made up of over 25 foundations cooperatively funding between $1-3 million to DIPG research every two years. In 2020, the DIPG Collaborative awarded a total of USD2,680,509 across six world-class research projects. Dr Ziegler’s grant is one of many that will be awarded this year through the Collaborative.

Dr. Hamza Anwer, Head of Research at CBCF says, “It is important that CBCF focuses on collaborations like this, especially when we’re starting to see real impacts for children with brain cancer. It is encouraging to see the impact of our collaborative funding in generating results for our community.”